BioNTech aims to develop the first mRNA malaria vaccine as well as the capacity to produce it in Africa ...Middle East

Quartz - Economy
BioNTech aims to develop the first mRNA malaria vaccine as well as the capacity to produce it in Africa
Following the remarkable success recorded for the mRNA Covid-19 vaccines, BioNTech has announced the launch of a project aimed at developing the first mRNA-based malaria vaccine with the clinical trial planned for the end of 2022. The German biotech company—which together with its US partner Pfizer developed the first-ever approved mRNA vaccine—now plans to use this technology to address this killer disease.If successful, the project will result in a malaria vaccine that may help to reduce the high rate of malaria deaths whose main impact is felt in Africa. Africa accounted for 94% of the 229 million cases of malaria and 409,000 malaria deaths in 2019, according to WHO.The project supported

Read More Details
Finally We wish PressBee provided you with enough information of ( BioNTech aims to develop the first mRNA malaria vaccine as well as the capacity to produce it in Africa )

Apple Storegoogle play

Also on site :